Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Ranjeet Maurya"'
Publikováno v:
STAR Protocols, Vol 5, Iss 2, Pp 103071- (2024)
Summary: The elucidation of the role of microorganisms in human infections has been hindered by difficulties using conventional culture-based techniques. Here, we present a protocol for the investigation of transcriptionally active microbes (TAMs) us
Externí odkaz:
https://doaj.org/article/0ca7df412bd34d98af80f9573290e593
Autor:
Shweta Verma, Sujit Dalabehera, Ranjeet Maurya, Dayanidhi Singh, Bhavana Prasher, Rajesh Pandey, Sharmila Bapat, Sivaprakash Ramalingam, Chetana Sachidanandan
Publikováno v:
Stem Cell Research, Vol 78, Iss , Pp 103456- (2024)
Rubinstein Taybi Syndrome (RSTS) is a rare genetic disorder which is caused by mutations in either CREBBP or EP300. RSTS with mutations in CREBBP is known as RSTS-1. We have generated an induced pluripotent stem cell (iPSC) line, IGIBi018-A from an I
Externí odkaz:
https://doaj.org/article/f56e9f250aee4719b19b365bc52e9f1e
Autor:
Aanchal Yadav, Uzma Shamim, Varsha Ravi, Priti Devi, Pallawi Kumari, Ranjeet Maurya, Poonam Das, Madhuri Somani, Sandeep Budhiraja, Bansidhar Tarai, Rajesh Pandey
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-13 (2023)
Abstract Dengue virus (DENV), known to cause viral infection, belongs to the family Flaviviridae, having four serotypes (DENV1-4) that spreads by the bite of the Aedes aegypti mosquito. India has been suffering from dengue outbreaks annually with wid
Externí odkaz:
https://doaj.org/article/d07f9dcc95cf4b18b3f5f3f97e4f88de
Autor:
Ranjeet Maurya, Aparna Swaminathan, Uzma Shamim, Smriti Arora, Pallavi Mishra, Aakarshan Raina, Varsha Ravi, Bansidhar Tarai, Sandeep Budhiraja, Rajesh Pandey
Publikováno v:
iScience, Vol 26, Iss 12, Pp 108336- (2023)
Summary: COVID-19 pandemic saw emergence of multiple SAR-CoV-2 variants. Exacerbated risk of severe outcome and hospital admissions led us to comprehend differential host-immune kinetics associated with SARS-CoV-2 variants. Longitudinal investigation
Externí odkaz:
https://doaj.org/article/2387562c85d4414b96f9c57505a592cd
Autor:
Ranjeet Maurya, Uzma Shamim, Pallavi Mishra, Aparna Swaminathan, Aakarshan Raina, Bansidhar Tarai, Sandeep Budhiraja, Rajesh Pandey
Publikováno v:
Microbiology Spectrum, Vol 11, Iss 3 (2023)
ABSTRACT Globally, COVID-19 vaccines have emerged as a boon, especially during the severe pandemic phases to control the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, saving millions of lives. However, mixed respo
Externí odkaz:
https://doaj.org/article/564feb2a11d9411996243cfa17a95aa8
Autor:
Janmejay Singh, Anbalagan Anantharaj, Aleksha Panwar, Chitra Rani, Monika Bhardwaj, Parveen Kumar, Partha Chattopadhyay, Priti Devi, Ranjeet Maurya, Pallavi Mishra, Anil Kumar Pandey, Rajesh Pandey, Guruprasad R Medigeshi
Publikováno v:
PLoS Pathogens, Vol 19, Iss 2, p e1011196 (2023)
The Omicron variant of SARS-CoV-2 is capable of infecting unvaccinated, vaccinated and previously-infected individuals due to its ability to evade neutralization by antibodies. With multiple sub-lineages of Omicron emerging in the last 12 months, the
Externí odkaz:
https://doaj.org/article/f1db0a193d7d4de08701bf1beb080344
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 12 (2023)
Cellulomonas sp. HM71, a human gut microbe possesses metabolic machinery to catabolize antigenic gluten, hence, holds promises as microbial therapy to treat gluten-derived celiac disease. However, its efficacy, safety, and survivability in the gastro
Externí odkaz:
https://doaj.org/article/0c9a6de5d4e74348b6f2e4cead0092e5
Autor:
Partha Chattopadhyay, Kriti Khare, Manish Kumar, Pallavi Mishra, Alok Anand, Ranjeet Maurya, Rohit Gupta, Shweta Sahni, Ayushi Gupta, Saruchi Wadhwa, Aanchal Yadav, Priti Devi, Kishore Tardalkar, Meghnad Joshi, Tavpritesh Sethi, Rajesh Pandey
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
IntroductionDespite numerous efforts to describe COVID-19's immunological landscape, there is still a gap in our understanding of the virus's infections after-effects, especially in the recovered patients. This would be important to understand as we
Externí odkaz:
https://doaj.org/article/15eb827758164ead8d0ac448e2126a3e
Autor:
Yogiraj Ray, Shekhar Ranjan Paul, Purbita Bandopadhyay, Ranit D’Rozario, Jafar Sarif, Deblina Raychaudhuri, Debaleena Bhowmik, Abhishake Lahiri, Janani Srinivasa Vasudevan, Ranjeet Maurya, Akshay Kanakan, Sachin Sharma, Manish Kumar, Praveen Singh, Rammohan Roy, Kausik Chaudhury, Rajsekhar Maiti, Saugata Bagchi, Ayan Maiti, Md. Masoom Perwez, Abhinandan Mondal, Avinash Tewari, Samik Mandal, Arpan Roy, Moumita Saha, Durba Biswas, Chikam Maiti, Ritwik Bhaduri, Sayantan Chakraborty, Biswanath Sharma Sarkar, Anima Haldar, Bibhuti Saha, Shantanu Sengupta, Rajesh Pandey, Shilpak Chatterjee, Prasun Bhattacharya, Sandip Paul, Dipyaman Ganguly
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-9 (2022)
Convalescent plasma therapy (CPT) is used to treat patients with Covid-19, but evidence for clinical benefit from clinical trials is divergent. Here the authors report in that CPT treatment does not affect mortality in patients with severe Covid-19 i
Externí odkaz:
https://doaj.org/article/61648fce8f2446988f7b6be76f0a7960
Publikováno v:
Frontiers in Microbiology, Vol 13 (2022)
Systemic characterization of the human gut microbiota highlighted its vast therapeutic potential. Despite having enormous potential, the non-availability of their culture representatives created a bottleneck to understand the concept of microbiome-ba
Externí odkaz:
https://doaj.org/article/26d55241ca3b4b9f882d94329ec90555